1. Home
  2. SOUNW vs DVAX Comparison

SOUNW vs DVAX Comparison

Compare SOUNW & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SoundHound AI Inc. Warrant

SOUNW

SoundHound AI Inc. Warrant

HOLD

Current Price

$4.90

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$10.84

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOUNW
DVAX
Founded
2005
1996
Country
United States
United States
Employees
842
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
1.3B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
SOUNW
DVAX
Price
$4.90
$10.84
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$26.50
AVG Volume (30 Days)
104.1K
1.5M
Earning Date
02-27-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$67,297,000.00
$330,514,000.00
Revenue This Year
N/A
$24.63
Revenue Next Year
N/A
$15.85
P/E Ratio
N/A
N/A
Revenue Growth
76.05
26.73
52 Week Low
$4.84
$9.20
52 Week High
$6.16
$14.63

Technical Indicators

Market Signals
Indicator
SOUNW
DVAX
Relative Strength Index (RSI) 41.78 48.59
Support Level $4.85 $10.71
Resistance Level $5.44 $11.00
Average True Range (ATR) 0.38 0.26
MACD 0.11 -0.06
Stochastic Oscillator 52.87 22.63

Price Performance

Historical Comparison
SOUNW
DVAX

About SOUNW SoundHound AI Inc. Warrant

SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: